Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fv-IgG) (BSDG-158)

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-EGFR IgG with similar domains from an anti-ZnO antibody via short peptide linkers, or vice versa. This BsAb can be used in immunoassay of Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors.

Datasheet INQUIRY

Specifications

Targets

EGFR & ZnO

Type

Appended IgGs

Species Reactivity

Human

Application

Immunoassay

Related Disease

Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors

Targets

Target 1

EGFR

Gene ID

1956

UniProt ID

P00533

Alternative Names

EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog

Target 2

ZnO

Alternative Names

ZnO; Zinc oxide

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fv-IgG) (BSDG-158). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (Fv-IgG) (CAT#: BSDG-158)

Specifications

Targets

Customer Reviews and Q&As